Assignee
EIRION THERAPEUTICS INC
US·1 granted patent·5 pending applications·2 citations·filing 2017–2022
Top patents by PatentIndex Score
6 records- 0181US11311496B2Transdermal delivery of large agentsEIRION THERAPEUTICS INC·Filed 2017·Granted Apr 26, 2022·2 cites·50 claims
- 0260US2022218623A1Transdermal delivery of large agentsEIRION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0349US2022031595A1Improved delivery of large agentsEIRION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0448US2022105068A1Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses thereforEIRION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0546US2022296503A1Delaying peak effect and/or extending duration of responseEIRION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0641US2022079911A1Uses of plasminogen activator inhibitor 1 (pai-1) inhibitorsEIRION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EIRION THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →